Disclosure Statement and Acknowledgements

Disclosure Statement and Acknowledgements

These modules were developed with funding support from the Association of American Medical Colleges and the Samueli Foundation and with sincere appreciation to the following:

Project Team:


Amber Baysinger, MD, PhD
Rich Bottner, PA-C, DHA
Alanna Boulton, MSHS
Kristin Escamilla, MD
Clarissa Johnston, MD
Sussann Kotara, MD
Christopher Moriates, MD
Victoria Valencia, MPH

Reviewers:


Robert Ashford, MSW
Honora Englander, MD
Deborah Finnell, DNS, CARN-AP
Lori Holleran Steiker, PhD, ACSW
William Kinkle, RN, EMT-P, CRS
Jennifer Potter, PhD, MPH
Kelsey Priest, PhD, MPH

Additional Contributors:


Communities for Recovery
University of Texas at Austin – Center for Health Communication
Lloyd Berg, PhD, AB>
Cody Cowley
Smitha Murthy, MD
Blake Smith

Target Audience: All practicing healthcare professionals and trainees

Learning Objectives:

Module 1: Changing Perceptions and Language to Improve Care for Patients with Opioid Use Disorder

1.1: Explain how stigma may contribute to decreased access to evidence-based care.
1.2: Compare perceptions and approaches to OUD to other chronic medical conditions.
1.3: Demonstrate how OUD-related stigma differs across diverse patient populations.
1.4: Identify and replace stigmatizing language used in relation to patients with OUD.

Module 2 Changing Behaviors to Save Lives for Patients with Opioid Use Disorder

2.1: Recognize one’s own biases, including implicit biases, and employ strategies to mitigate bias.
2.2: Develop improved communication skills, including motivational interviewing, for interacting with patients with OUD.
2.3: Demonstrate the importance of access to naloxone and medications for the treatment of OUD.

Leave a Comment